# Accelerated low-intensity iTBS reduces depression severity and suicide risk in major depressive disorder: a randomized controlled trial - URL: https://alisanburak.com/en/wcp-2026-posterler/ev0882 - Language: en - Last updated: not specified - Page title: Accelerated low-intensity iTBS reduces depression severity and suicide risk in major depressive disorder: a randomized controlled trial | WCP 2026 Summary > Accelerated low-intensity intermittent theta-burst stimulation administered over four days produced significant reductions in depressive symptoms and suicidal… This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/ev0882) This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it. EV0882 E-PosterNeuromodulationRCT # Accelerated low-intensity iTBS reduces depression severity and suicide risk in major depressive disorder: a randomized controlled trial ACCELERATED LOW-INTENSITY ITBS REDUCES DEPRESSION SEVERITY AND SUICIDAL RISK IN MAJOR DEPRESSIVE DISORDER: A RANDOMIZED CONTROLLED TRIAL Presenter: Olga Estefania Escobar Florez Country: Mexico Institution: University of Guanajuato, Department of Medical Sciences, Health Sciences Division Accelerated low-intensity intermittent theta-burst stimulation administered over four days produced significant reductions in depressive symptoms and suicidal ideation compared with sham stimulation. The study aimed to evaluate the antidepressant and antisuicidal effects of accelerated low-intensity intermittent theta-burst stimulation (Li-iTBS) in patients with major depressive disorder. In this single-blind, sham-controlled randomized controlled trial using an accelerated protocol, 173 individuals were assessed for eligibility, 125 were excluded, and 48 patients were randomized (active Li-iTBS n = 23, sham n = 25); due to incomplete treatment sessions and unavailable final assessments, 39 patients (active n = 20, sham n = 19) were included in the analysis. The intervention was delivered to the left dorsolateral prefrontal cortex in a total of 20 sessions, with 5 sessions per day over 4 consecutive days, using bursts of three pulses at 50 Hz, lasting 200 seconds per session at an intensity of 3.9 to 4.9 mT; assessments used the HDRS-17, PHQ-9, and HDRS item 3 for suicidal ideation. The reduction in HDRS-17 scores was significantly greater in the active group than in the sham group (p < 0.001). The response rate was reported as 90% (18/20) in the active group and 10.5% (2/19) in the sham group (p < 0.001); the remission rate was 40% (8/20) in the active group and 0% (0/19) in the sham group (p < 0.002). PHQ-9 scores decreased from 14.5 ± 6.5 to 5.1 ± 4.4 in the active group (n = 18) and from 19.0 ± 5.0 to 12.8 ± 6.0 in the sham group (n = 19), with a significant between-group difference (p = 0.014). Following accelerated Li-iTBS, no suicidal ideation was detected in 95% of patients (post-treatment p = 0.016). The authors state that the protocol was well tolerated and that low-intensity neuromodulation may offer an accessible treatment option for major depressive disorder. [View the original poster](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1198) How to cite this study APA 7: Florez, O. E. E., et al. (2026, September 23-26). Accelerated low-intensity itbs reduces depression severity and suicidal risk in major depressive disorder: a randomized controlled trial [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1198 Vancouver: Florez OEE, et al. Accelerated low-intensity itbs reduces depression severity and suicidal risk in major depressive disorder: a randomized controlled trial [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1198 Author names and title formatting were generated automatically from the congress system; please check them against the original poster before use. ## On the same topic - [Kumar oynama bozukluğunda teta patlama uyarımının klinik etkinliği ve plasebo etkileri: başlangıçtaki anksiyete ve depresyonun rolü](https://alisanburak.com/en/wcp-2026-posterler/ev0055) - [Transkraniyal darbe uyarımı (TPS) Alzheimer hastalığı olan hastalarda uygun bir ek tedavi mi?](https://alisanburak.com/en/wcp-2026-posterler/ev0407) - [Demansta tedaviye dirençli ajitasyonda elektrokonvulsif tedavi: anlatısal derleme](https://alisanburak.com/en/wcp-2026-posterler/ev0414) - [Elektrokonvulsif tedavi sonrası bilişsel değişimin nöroimmün ve psikolojik mekanizmaları: boylamsal MITO-ECT çalışmasının ön sonuçları](https://alisanburak.com/en/wcp-2026-posterler/ev0825) - [Yetişkin tedaviye dirençli depresyon hastalarında DEHB belirtilerini iyileştiren güçlendirilmiş tDCS'nin klinik ve görüntüleme mekanizmaları](https://alisanburak.com/en/wcp-2026-posterler/ev0851) [All WCP 2026 summaries](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/ev0882 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim